Javier A. Pinilla-Ibarz
Affiliations: | Biology (Cell Biology, Microbiology, Molecular Biology) | University of South Florida, Tampa, FL, United States |
Area:
Cell Biology, Immunology, Molecular BiologyGoogle:
"Javier Pinilla-Ibarz"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Faramand RG, Lee SB, Jain MD, et al. (2024) Baseline serum inflammatory proteins predict poor CAR T outcomes in diffuse large B-cell lymphoma. Blood Cancer Discovery |
| Radich JP, Wall M, Branford S, et al. (2023) Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica |
| Gamal W, Sahakian E, Pinilla-Ibarz J. (2022) The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? Blood Advances |
| Gaballa S, Pinilla-Ibarz J. (2021) BTK Inhibitors in Chronic Lymphocytic Leukemia. Current Hematologic Malignancy Reports. 16: 422-432 |
| Maharaj K, Powers JJ, Mediavilla-Varela M, et al. (2020) HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. Frontiers in Immunology. 11: 590072 |
| Al-Sawaf O, Zhang C, Tandon M, et al. (2020) Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial. The Lancet. Oncology. 21: 1188-1200 |
| Hashmi H, Mirza AS, Darwin A, et al. (2020) Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma. Blood Advances. 4: 4086-4090 |
| Dean EA, Mhaskar RS, Lu H, et al. (2020) High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances. 4: 3268-3276 |
| Maharaj K, Powers JJ, Achille A, et al. (2020) The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells. Blood Advances. 4: 3072-3084 |
| Aulakh S, Reljic T, Yassine F, et al. (2020) Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis. Hematology/Oncology and Stem Cell Therapy |